Phase I/II safety and antitumor activity of nivolumab in patients with advanced hepatocellular carcinoma (HCC): CA209-040.

Anthony B. El-Khoueiry, Ignacio Melero, Todd S. Crocenzi, Theodore H. Welling, Thomas Cheung Yau, Winnie Yeo, Akhil Chopra, Joseph F. Grosso, Lixin Lang, Jeffrey Anderson,

Journal of Clinical Oncology · 2015 · 41 citations · 0 references

Concepts

Abstract

LBA101 The full, final text of this abstract will be available at abstracts.asco.org at 2:00 PM (EDT) on Friday, May 29, 2015, and in the Annual Meeting Proceedings online supplement to the June 20, 2015, issue of the Journal of Clinical Oncology. Onsite at the Meeting, this abstract will be printed in the Saturday edition of ASCO Daily News.